1. Introduction {#sec1-molecules-22-01098}
===============

*Prangos* is an important genus of Apiaceae family, with 43 species known worldwide \[[@B1-molecules-22-01098]\]. There are 17 species of *Prangos* in Turkey; nine of them are endemic \[[@B2-molecules-22-01098]\]. Members of this genus have carminative, laxative, stomachic, stimulant, emmenagogue, antienflammatuar, antimicrobial, and antidiabetic properties, and are used for the treatment of burns, hemorrhoids, and wounds \[[@B3-molecules-22-01098],[@B4-molecules-22-01098],[@B5-molecules-22-01098],[@B6-molecules-22-01098]\]. Many coumarin, alkaloid, flavonoid, and terpenoid derivatives were isolated from the roots, aerial parts, and fruits of *Prangos* species \[[@B7-molecules-22-01098],[@B8-molecules-22-01098],[@B9-molecules-22-01098],[@B10-molecules-22-01098]\]. *Prangos hulusii* (S. G. Şenol, H. Yıldırım & Ö. Seçmen) is a newly identified endemic species from Flora of Turkey \[[@B11-molecules-22-01098]\]. Preliminary biological activity studies on the extracts of the roots of *P. hulusii* showed the presence of antimicrobial and cytotoxic activities \[[@B12-molecules-22-01098]\].

The dichloromethane extract of the roots of *P. hulusii* was subjected to a series of chromatographic separations to yield a new coumarin, 4′-senecioiloxyosthol (**1**), along with nine known coumarins; osthol (**3**) \[[@B13-molecules-22-01098]\], murraol (**4**) \[[@B14-molecules-22-01098]\], auraptenol (**5**) \[[@B15-molecules-22-01098]\], meranzin (**6**) \[[@B16-molecules-22-01098]\], hydroxyosthol-epoxide (**7**) \[[@B17-molecules-22-01098]\], meranzin hydrate (**8**) \[[@B16-molecules-22-01098]\], isoimperatorin (**9**) \[[@B18-molecules-22-01098]\], oxypeucedanin (**10**) \[[@B18-molecules-22-01098]\], psoralen (**11**) \[[@B19-molecules-22-01098]\], and two phytosterols; stigmasterol and β-sitosterol \[[@B20-molecules-22-01098]\]. Structures of the isolated compounds ([Figure 1](#molecules-22-01098-f001){ref-type="fig"}) were elucidated using spectroscopic techniques and chemical transformations as well as by direct comparison with the reference standards where available. Antimicrobial activities of the dichloromethane extract of the roots of *P. hulusii* and prenylated coumarins isolated from this extract were investigated against the standard and clinically isolated 15 bacterial strains.

2. Results and Discussion {#sec2-molecules-22-01098}
=========================

4′-Senecioiloxyosthol (**1**) was obtained as a colorless gum. The HRESIMS spectrum of **1** suggests a molecular formula of C~20~H~22~O~5~ with 10 degrees of unsaturation based on the \[M + H\]^+^ molecular peak at *m*/*z* 343.1544 (calcd *m*/*z* 343.1545). The ^1^H-NMR spectrum ([Table 1](#molecules-22-01098-t001){ref-type="table"}) of **1** was very similar to that of osthol \[[@B13-molecules-22-01098],[@B16-molecules-22-01098]\], with the exception of a missing vinylic methyl group signal of the prenyl side chain of osthol. Instead of two vinylic methyl signals, the ^1^H-NMR spectrum of **1** displayed a vinylic methyl group signal at δ~H~ 1.72 (3H) and a methylene singlet at δ~H~ 4.87 (2H), indicating that the second vinylic methyl group of osthol side chain was replaced with an acyloxy bearing methylene group. Furthermore, the typical vinylic narrow quintet proton signal observed at δ~H~ 5.72 (*J* = 1.3 Hz) along with the two vinylic methyl group doublets at δ~H~ 2.19 and 1.90 (each 3H, *J* = 1.3 Hz) suggest the presence of a senecioil group as the acyl group. The 2D-ROESY spectrum of **1** exhibited interactions between C-5′ methyl group protons and H-2′ proton of the prenylated side chain of osthol ([Figure 2](#molecules-22-01098-f002){ref-type="fig"}) as well as displayed interactions between H-6 and the methoxy group protons at C-7, and H-2″ proton and H-4″ methyl protons of the senecioiloxy acyl group, which clearly confirms the presence of a senecioiloxy acyl group at the C-4′ methyl group of osthol in **1**. Furthermore, ^13^C-NMR ([Table 1](#molecules-22-01098-t001){ref-type="table"}), 2D COSY, UV and IR spectroscopic data (see experimental section and supplemental data) of **1** corroborated the structure as 4′-senecioiloxyosthol. Previously, 4′-angeloiloxy derivative of osthol (**2**) (i.e., macrocarpin) was reported from *Lomatium macrocarpum* (Hook. & Arn.) C. & R., another Apiaceaen plant \[[@B21-molecules-22-01098]\]. The ^1^H-NMR spectroscopic data reported for macrocarpin (**2**) were similar to that of **1** with the exception of the presence of angeloiloxy acyl group signals \[i.e., δ~H~ 6.04 (1H, br t), 1.97 (3H) and 1.88 (3H)\] instead of a senecioiloxy acyl group signals.

The antimicrobial activity of extracts and isolated coumarins of *Prangos hulusii* was evaluated against Gram-positive and Gram-negative nine reference standards and six clinically isolated microorganism strains. The results of minimum inhibition concentration (MIC, in µg/mL) values are summarized in [Table 2](#molecules-22-01098-t002){ref-type="table"}. The best antimicrobial activity was observed against *Escherichia coli* with the dichlormethane (DCM) extract (i.e., MIC at 156 µg/mL), followed by the petroleum ether (PE) and methanol (MeOH) extracts (i.e., each MIC at 313 µg/mL). All three extracts showed good activity against *Enterococcus faecalis* (MIC at 313 µg/mL). Similar activities were detected with the DCM extract against *Proteus mirabilis*, with the PE extract against *Staphylococcus aureus* and with the MeOH extract against *Klebsiella pneumoniae* ATCC 4352*.* No activity was observed with all of the tested extracts against clinical isolates *K. pneumoniae*, *Acinetobacter baumannii*, and *E. coli*, and only a weak activity was detected against other reference and clinical isolate bacteria.

The new coumarin, 4′-senecioiloxyosthol (**1**), showed the best activity against *Bacillus subtilis* ([Table 2](#molecules-22-01098-t002){ref-type="table"}) (MIC at 5 µg/mL), whereas the structurally related osthol (**3**) and isoimperatorin (**9**) displayed very good activity against clinical isolate Methicillin-resistant *Staphylococcus aureus* (MRSA) (MIC at 16 µg/mL), similar to the reference antibiotic Cefotaxime (CEF) (see [Table 2](#molecules-22-01098-t002){ref-type="table"}). In contrast, auraptenol (**5**) and murraol (**4**) exhibited good activity against *K. pneumoniae* ATCC 4352 and *Bacillus subtilis* ATCC 9372 (MIC at 63 µg/mL) and poor activity against Methicillin Resistant Coagulase-Negative *Staphylococci* (MRCNS) (MIC at 125 µg/mL). Furthermore, auraptenol (**5**) displayed a good activity against *Staphylococcus epidermidis* ATCC 12228 and MRCNS (MICs at 63 and 125 µg/mL, respectively), osthol (**3**) against *B. subtilis* ATCC 9372, *S. aureus* ATCC 25923, *K. pneumoniae* ATCC 4352 and Methicillin-sensitive *Staphylococcus aureus (*MSSA) (all MICs at 125 µg/mL).

The antimycobacterial activity of prenylated coumarins and prenylated furanocoumarins \[[@B22-molecules-22-01098],[@B23-molecules-22-01098]\] as well as the antimicrobial activity of furanocoumarins and prenylated furanocoumarins were reported previously \[[@B24-molecules-22-01098]\]. In the latter publication, xanthotoxin (8-methoxyfuranocoumarin) was described as the most potent compound against *B. subtilis* ATCC 6633 strain with an MIC value at 30 µg/mL, whereas the new prenylated coumarin 4′-senecioiloxyosthol (**1**) was 6-fold more active against *B. subtilis* ATCC 9372 than that of xanthotoxin, with an MIC value at 5 µg/mL.

3. Materials and Methods {#sec3-molecules-22-01098}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-22-01098}
------------------------------------

UV spectra were recorded on a UV-1700 PharmaSpec Shimadzu spectrophotometer (Shimadzu Corp., Kyoto, Japan) in MeOH. IR spectra were measured with a PerkinElmer Spectrum 2000 FT-IR spectrometer (PerkinElmer Corp., Waltham, MA, USA). NMR experiments were conducted on a Varian Mercury FT-NMR 400 MHz spectrometer (Agilent Corp., Santa Clara, CA, USA) using tetramethylsilane (TMS) as an internal standard. High Resolution Electrospray Ionization Mass Spectra (HRESIMS) and Electrospray Ionization Mass Spectra (ESIMS) were determined on Waters SYNAPT G1 mass spectrometer (Waters Corp., Milford, MA, USA).

3.2. Plant Material {#sec3dot2-molecules-22-01098}
-------------------

The roots of *Prangos hulusii* were collected from Ödemiş by Hulusi Kütük, İzmir on March 2012, in Turkey. The plant was identified by Professor Emine Akalin Uruşak and a voucher specimen was deposited in the Herbarium of Istanbul University, Faculty of Pharmacy (ISTE 99676).

3.3. Isolation of Compounds {#sec3dot3-molecules-22-01098}
---------------------------

The dried and coarsely powdered roots (835 g) were exhaustively extracted with PE, DCM and MeOH, sequentially, using a Soxhlet Apparatus. The solvents were evaporated under reduced pressure in a rotary evaporator. The dichloromethane extract (55.6 g) was dissolved in acetone (2000 mL), and kept in a refrigerator overnight. Following the removal of precipitated hydrocarbon mixtures by filtration, the solvent was removed in vacuo to yield 45.8 g viscous oil. A portion of the defatted extract (5 g) was chromatographed on a Sephadex LH-20 (5 cm × 60 cm) packed in hexane-dichloromethane-methanol (7:4.5:0.5) and Preparative Thin Layer Chromatography (prep. TLC) (1-2 mm thickness, silica gel developed with cyclohexane-EtOAc mixtures, 4:1, 3:2, 1:1) was used for the final purification of compounds. 4′-senecioiloxyosthol (**1**) (4.7 mg), osthol (**3**) (39 mg), murraol (**4**) (5 mg), auraptenol (**5**) (8.2 mg), meranzin (**6**) (7 mg), hydroxyosthol-epoxide (**7**) (4 mg), meranzin hydrate (**8**) (12 mg), isoimperatorin (**9**) (23 mg), oxypeucedanin (**10**) (60 mg), psoralen (**11**) (7 mg), stigmasterol (3 mg), and β-sitosterol (2.8 mg) were isolated. Furthermore, meranzin (**6**) (11.3 mg), meranzin hydrate (**8**) (10.2 mg), and auraptenol (**5**) (7.6 mg) were prepared from osthol (**3**) semi-synthetically \[[@B16-molecules-22-01098]\] as a reference material.

3.4. 4′-Senecioiloxyosthol (**1**) {#sec3dot4-molecules-22-01098}
----------------------------------

IR (KBr) ν~max~: 2970, 2915, 2842, 1732, 1717, 1651, 1608, 1281, 1251, 1226, 1145, 1118, 1090 and 832 cm^−1^. UV (MeOH) λ~max~ (log ε) 321 (4.06), 258(sh) (3.82), 247 (3.26) and 224(sh) (3.81) nm. For ^1^H (CDCl~3~, 400 MHz) and ^13^C-NMR (CDCl~3~, 100 MHz) spectroscopic data, see [Table 1](#molecules-22-01098-t001){ref-type="table"}; HRESIMS *m*/*z*: 343.1544 (calcd for C~20~H~23~O~5~ 343.1545).

3.5. Antimicrobial Activity {#sec3dot5-molecules-22-01098}
---------------------------

The antimicrobial activity of the extracts and isolated coumarins of *Prangos hulusii* was evaluated against nine reference standard microorganisms, both Gram-positive and Gram-negative; *S. aureus* ATCC 25923, *S. epidermidis* ATCC 12228, *E. faecalis* ATCC 29212, *Pseudomonas aeruginosa* ATCC 27853, *E. coli* ATCC 10799, *K. pneumoniae* ATCC 4352, *Salmonella choleraesuis* ATCC 14028, *P. mirabilis* ATCC 7002, *B. subtilis* ATCC 9372*,* and six clinical isolates; (MSSA), (MRSA), (MRCNS), *K. pneumoniae*, *A. baumannii*, *E. coli*, by using a standard microbroth dilution method modified with rezasurin \[[@B25-molecules-22-01098],[@B26-molecules-22-01098]\]. The experiments were performed with two replications and the results were expressed as average values.

3.6. Determination of Antibacterial Activity {#sec3dot6-molecules-22-01098}
--------------------------------------------

The MIC values of extracts and isolated compounds were determined using microbroth dilution method in 96-well microtitre plates. The bacterial cultures were prepared from overnight cultures on Tryptic Soy Agar (TSA) at 37 °C for 24 h by diluting in Mueller Hinton Broth (MHB) from approx. 10^8^ CFU/mL to 2 × 10^6^ CFU/mL. Then, 50 μL Mueller Hinton Broth (MHB) was added to the wells starting from the first well and continuing up to the twelfth. The extracts and isolated compounds were prepared 1/10 (*v*/*v*) in DMSO and 50 μg/mL of these were added to the first wells. Two-fold serial dilutions were made, achieving a final concentration ranging from 5000 to 10 μg/mL. The positive controls for Ciprofloxacin (CPR), Tetracycline (TTR), Cefotaxime (CEF), and Oxacillin (OXA) were determined with the final concentrations from 64 to 0.1 µg/mL. In addition, an extra row of DMSO was used as a vehicle control to determine its possible inhibitory activity. Finally, 25 μL of bacterial suspensions and % 0.001 resazurin solution were added to each well.

After incubating the bacteria at 37 °C for 24 h, the microtitre plates were examined visually for microbial growth which appeared as pink, colored by resazurin dye. In each row, the well containing the least concentration that showed no visible growth was considered the MIC. The bacterial samples were inoculated on TSA plates and incubated at 37 °C for 24 h.

4. Conclusions {#sec4-molecules-22-01098}
==============

Investigation of the dichloromethane extract of the roots of *P. hulusii* yielded several pyrenylated coumarins and furanocoumarins with antimicrobial activities. *Prangos* species frequently used for the treatment of burns and wounds in traditional folk medicine \[[@B3-molecules-22-01098],[@B4-molecules-22-01098],[@B5-molecules-22-01098],[@B6-molecules-22-01098]\], perhaps the presence of pyrenylated coumarins with antimicrobial activity may play an important role for the aforementioned folkloric use of *Prangos* species.
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molecules-22-01098-t001_Table 1

###### 

^1^H-NMR and ^13^C-NMR data of Compound **1**.

  Positions   Δ~H~ (*J* in Hz)       Δ~C~, Type
  ----------- ---------------------- --------------
  2                                  161.14, C
  3           6.23 d (9.8), 1H       116.08, CH
  4           7.60 d (9.8), 1H       143.65, CH
  5           7.30 d (8.4), 1H       126.46, CH
  6           6.82 d (8.4), 1H       107.3, CH
  7                                  160.09, C
  8                                  116.66, C
  9                                  152.86, C
  10                                 112.92, C
  -OCH~3~     3.89 s, 3H             56.01, CH~3~
  1′          3.62 d (7.9), 2H       21.45, CH~2~
  2′          5.50 br t (7.9), 1H    113.04, CH
  3′                                 131.24, C
  4′          4.87 s, 2H             62.40, CH~2~
  5′          1.72 br s, 3H          21.61, CH~3~
  1″                                 166.8, C
  2″          5.72 quint (1.3), 1H   126.51, CH
  3″                                 156.41, C
  4″          1.90 br d (1.3), 3H    27.39, CH~3~
  5″          2.17 br d (1.3), 3H    20.2, CH~3~

molecules-22-01098-t002_Table 2

###### 

Antimicrobial activity of the prenylated coumarins and root extracts of *P. hulusii*.

  Test Strains                                                       Prenylated Coumarins (μg/mL) \*\*   Extracts (μg/mL) \*\*\*   References \*\*\*\*                                                                                 
  ------------------------------------------------------------------ ----------------------------------- ------------------------- --------------------- ------- ------- ----- ------- ----- ------ ------ ------ ------ ------ ------ ------
  *S. epidermidis* ATCC 12228                                        625                                 \>125                     \>125                 63      \>125   125   \>125   125   625    313    625    64     0.5    4      0.5
  *S. aureus* ATCC 25923                                             625                                 125                       \>250                 \>250   \>250   250   \>250   250   1250   625    1250   0.5    0.5    2      1
  *E. faecalis* ATCC 29212                                           313                                 \>250                     \>250                 \>250   \>250   250   \>250   250   313    313    313    16     8      2      1
  *K. pneumoniae* ATCC 4352                                          313                                 125                       63                    63      125     250   125     250   625    625    313    8      4      2      0.5
  *B. subtilis* ATCC 9372                                            5                                   125                       63                    63      \>250   250   \>250   125   1250   1250   1250   0.3    0.1    0.5    0.5
  *E. coli* ATCC 10799                                               313                                 \>125                     \>125                 \>125   \>125   250   \>125   250   156    313    313    2      32     1      0.3
  *P. aeruginosa* ATCC 27853                                         156                                 \>125                     \>125                 \>125   \>125   250   \>125   125   313    313    625    32     \>64   16     0.5
  *S. choleraesuis* ATCC 14028                                       313                                 \>125                     \>125                 \>125   \>125   125   \>125   125   625    625    1250   4      \>64   0.3    0.3
  *P. mirabilis* ATCC 7002                                           313                                 \>125                     \>125                 \>125   \>125   250   \>125   250   313    625    625    64     32     1      1
  Methicillin-sensitive *Staphylococcus aureus* (MSSA)               625                                 125                       \>250                 \>250   \>250   250   \>250   250   1250   1250   2500   64     64     2      0.1
  Methicillin-resistant *Staphylococcus aureus* (MRSA)               625                                 16                        \>250                 \>250   \>250   250   16      125   1250   1250   2500   8      8      16     0.5
  Methicillin Resistant Coagulase-Negative *Staphylococci* (MRCNS)   313                                 \>250                     125                   125     125     125   \>250   125   1250   1250   1250   8      8      16     4
  *K. pneumoniae*                                                    313                                 \>125                     \>125                 \>125   \>125   250   \>125   250   2500   2500   2500   2      \>64   \>64   2
  *A. baumannii*                                                     n.t.                                \>125                     \>125                 \>125   \>125   125   \>125   125   2500   1250   2500   n.t.   n.t.   n.t.   \>16
  *E. coli*                                                          156                                 \>125                     \>125                 \>125   \>125   250   \>125   250   2500   2500   2500   \>64   \>64   \>64   0.5

Starting concentrations: \* 1250 μg/mL; \*\* 250 μg/mL; \*\*\* 5000 μg/mL; \*\*\*\* 64 μg/mL. TTR = Tetracycline, OXA = Oxacilline, CEF = Cefotaxime, CPR = Ciprofloxacin. n.t.: not tested PE: petroleum ether; DCM: dichlormethane; MeOH: methanol.
